Bronchodilator effects of indacaterol and formoterol in patients with Copd

J. Beier , K-M. Beeh , S. Pascoe , L. Brookman , G. Peachey , A. Hmissi

Resting inspiratory capacity (IC) reflects static hyperinflation in chronic obstructive pulmonary disease (COPD). This study compared the effects of formoterol and indacaterol, a novel once-daily ultra-long-acting β-agonist (or ultra-LABA), on resting IC and forced expiratory volume in 1second (FEV).

Mots clés: bronchodilation; chronic obstructive pulmonary disease; forced expiratory volume in 1second; formoterol; indacaterol; inspiratory capacity

J. Beier, K-M. Beeh, S. Pascoe, L. Brookman, G. Peachey, et al.. Bronchodilator effects of indacaterol and formoterol in patients with Copd. Pulmonary Pharmacology & Therapeutics, 2009, 22 (6), pp.492. ⟨10.1016/j.pupt.2009.05.001⟩. ⟨hal-00589449⟩